[go: up one dir, main page]

AU2648295A - Safe retroviral vectors, their production and use - Google Patents

Safe retroviral vectors, their production and use

Info

Publication number
AU2648295A
AU2648295A AU26482/95A AU2648295A AU2648295A AU 2648295 A AU2648295 A AU 2648295A AU 26482/95 A AU26482/95 A AU 26482/95A AU 2648295 A AU2648295 A AU 2648295A AU 2648295 A AU2648295 A AU 2648295A
Authority
AU
Australia
Prior art keywords
production
retroviral vectors
safe
safe retroviral
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26482/95A
Inventor
Chien-Hsing Chang
Shui-On Leung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of AU2648295A publication Critical patent/AU2648295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU26482/95A 1994-06-07 1995-06-07 Safe retroviral vectors, their production and use Abandoned AU2648295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25577194A 1994-06-07 1994-06-07
US255771 1994-06-07
PCT/US1995/006594 WO1995033842A1 (en) 1994-06-07 1995-06-07 Safe retroviral vectors, their production and use

Publications (1)

Publication Number Publication Date
AU2648295A true AU2648295A (en) 1996-01-04

Family

ID=22969789

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26482/95A Abandoned AU2648295A (en) 1994-06-07 1995-06-07 Safe retroviral vectors, their production and use

Country Status (3)

Country Link
EP (1) EP0763123A4 (en)
AU (1) AU2648295A (en)
WO (1) WO1995033842A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200811B1 (en) * 1996-04-02 2001-03-13 The Regents Of The University Of California Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03504079A (en) * 1988-03-21 1991-09-12 カイロン　コーポレイション recombinant retrovirus
JP2752788B2 (en) * 1989-01-23 1998-05-18 カイロン コーポレイション Recombinant therapy for infection and hyperproliferative disorders
WO1990012087A1 (en) * 1989-04-05 1990-10-18 Novacell Corporation Infectious targetted replication-defective virion
EP1645635A3 (en) * 1989-08-18 2010-07-07 Oxford Biomedica (UK) Limited Replication defective recombinant retroviruses expressing a palliative
EP0854193A1 (en) * 1990-09-21 1998-07-22 Chiron Corporation Human retroviral packaging cell line
GB9104165D0 (en) * 1991-02-27 1991-04-17 Wellcome Found Novel entities for hiv therapy

Also Published As

Publication number Publication date
EP0763123A4 (en) 1998-08-12
WO1995033842A1 (en) 1995-12-14
EP0763123A1 (en) 1997-03-19

Similar Documents

Publication Publication Date Title
AU7693396A (en) Poly(9,9'-spiro-bisfluorenes), the production and use of same
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
AU4772597A (en) Novel phospholipase, production and use thereof
AU3660795A (en) Oxazolidinedione derivatives, their production and use
AU2687395A (en) Safety apparel
AU9075591A (en) N-halochitosans, their preparation and uses
HU9501086D0 (en) Organoaluminoxy product, preparation and use
AU4504696A (en) Expressed chemokines, their production and uses
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
AU7095296A (en) Phosphorylamides, their preparation and use
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU2935895A (en) Tricyclic compounds, their production and use
AU628227B2 (en) Benzoxazinyl-pyrazoles, and their production and use
GB2294941B (en) Dyestuff mixtures, their production and use
AU8271191A (en) Indolonaphthyridines, their production and use
AU683040B2 (en) Improved iodophors, production and use thereof
AU4115796A (en) Iminooxymethylene anilides, process for preparing the same and their use
AU5468896A (en) Polypeptides, their production and use
AU7001396A (en) Triazole compounds, their production and use
AU6531196A (en) Triazolone derivatives, use of the same and intermediates in the production of the same
HUP0000498A3 (en) Novel calpaines, production and use thereof
PL319406A1 (en) Novel heterocyclically substituted imidazoqunoxalinones, their production and application
EP0446877A3 (en) Triazoles, their production and use
AU2648295A (en) Safe retroviral vectors, their production and use
AU9263598A (en) New tissue-specific calpaines, their production and their use